TP53 mutations in circulating tumor DNA for response monitoring in patients with high grade serous carcinoma of ovary

被引：0
|
作者：
Kim, Y. M. [1 ]
Lee, S. W. [1 ]
Lee, H. Y. [2 ]
Lee, S. E. [2 ]
Park, Y. R. [3 ]
Kim, J. H. [1 ]
Kim, Y. T. [1 ]
Nam, J. H. [1 ]
机构：
[1] Univ Ulsan, Coll Med, ASAN Med Ctr, Seoul, South Korea
[2] Asan Inst Life Sci, Seoul, South Korea
[3] Asan Med Ctr, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：12 / 13
页数：3
相关论文
共 50 条
  • [1] Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
    Ahmed, Ashour Ahmed
    Etemadmoghadam, Dariush
    Temple, Jillian
    Lynch, Andy G.
    Riad, Mohamed
    Sharma, Raghwa
    Stewart, Colin
    Fereday, Sian
    Caldas, Carlos
    DeFazio, Anna
    Bowtell, David
    Brenton, James D.
    [J]. JOURNAL OF PATHOLOGY, 2010, 221 (01): : 49 - 56
  • [2] Circulating TP53 mutations as a biomarker of high-grade serous cancer
    Christie, Elizabeth
    Hunter, Tane
    Bowtell, David
    [J]. CLINICAL CANCER RESEARCH, 2015, 21
  • [3] Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
    Lee, Y. J.
    Kim, Y. M.
    Lee, S. W.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 270 - 270
  • [4] Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
    Kim, Yong-Man
    Lee, Shin-Wha
    Lee, Young-Jae
    Lee, Ha-Young
    Lee, Jong-Eun
    Choi, Eun-Kyung
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (03)
  • [5] Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
    Parkinson, Christine A.
    Gale, Davina
    Piskorz, Anna M.
    Biggs, Heather
    Hodgkin, Charlotte
    Addley, Helen
    Freeman, Sue
    Moyle, Penelope
    Sala, Evis
    Sayal, Karen
    Hosking, Karen
    Gounaris, Ioannis
    Jimenez-Linan, Mercedes
    Earl, Helena M.
    Qian, Wendi
    Rosenfeld, Nitzan
    Brenton, James D.
    [J]. PLOS MEDICINE, 2016, 13 (12)
  • [6] Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies
    Calapre, Leslie
    Giardina, Tindaro
    Beasley, Aaron B. B.
    Reid, Anna L. L.
    Stewart, Colin
    Amanuel, Benhur
    Meniawy, Tarek M. M.
    Gray, Elin S. S.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies
    Leslie Calapre
    Tindaro Giardina
    Aaron B. Beasley
    Anna L. Reid
    Colin Stewart
    Benhur Amanuel
    Tarek M. Meniawy
    Elin S. Gray
    [J]. Scientific Reports, 13
  • [8] TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Ovarian High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Soslow, R. A.
    Han, G.
    Wang, T-L
    Shih, I-M
    [J]. MODERN PATHOLOGY, 2011, 24 : 253A - 254A
  • [9] TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Ovarian High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Saslow, R. A.
    Han, G.
    Wang, T-L
    Shih, I-M
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 253A - 254A
  • [10] TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma
    Montemorano, Lauren
    Shultz, Zoey B.
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard J.
    Hartenbach, Ellen M.
    Lang, Jessica D.
    [J]. GYNECOLOGIC ONCOLOGY, 2024, 186 : 26 - 34
12345